Massachusetts Institute of Technology
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Massachusetts Institute of Technology sits in the top decile of US sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count).
Massachusetts Institute of Technology: 24 sponsored US clinical trials, 10 recruiting.
Massachusetts Institute of Technology sponsors 24 registered US clinical trials on ClinicalTrials.gov, 10 of them currently recruiting, and 7 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimer Disease, with 3 trials.
Top-decile sponsor footprint
Massachusetts Institute of Technology ranks in the top decile of sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
24 total, page 1 of 1
Study of Wearable Interventions for Improving Mobility of Individuals With Knee Osteoarthritis
NCT07652437
Investigating the Effects of Social Stress on Brain Imaging
NCT05591404
Evaluation of a Powered Ankle Prosthesis Capable of Bidirectional Control Via Neural Recording and Cutaneous Stimulation in Free-Space and Walking Tasks
NCT07645729
Investigating the Effects of Cannabidiol on Social Anxiety Disorder
NCT05649059
Evaluation of a Neural-Controlled Powered Prosthesis Across Diverse Real-World Tasks
NCT07204912
Wellness Program Outreach and Effectiveness
NCT06725511
Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
NCT05655195
High Frequency Light, Sound, and Tactile Stimulation to Improve Motor and Cognitive Deficits in Parkinson's Disease
NCT05268887
Gamma Frequency Stimulation in Individuals With Down Syndrome
NCT05196984
Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices)
NCT07496918
Effects of Altered Auditory Feedback on Speech Fluency
NCT06011837
Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease
NCT04055376
High Frequency Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease
NCT04042922
An Osseointegrated Transfemoral Prosthesis Offering Long-Term Bi-Directional Efferent-Afferent Neural Transmission
NCT07615465
Active Knee Prosthesis Study
NCT06700668
Transcranial Ultrasonic Neuromodulation of Primary Visual Cortex and Primary Auditory Cortex in Humans
NCT07508722
Gamma Light and Sound Stimulation in Schizophrenia
NCT07342465
Smartphone Mindfulness Autism Research Study
NCT05880498
COVID-19 Messaging for Vaccination
NCT05182554
Agonist-Antagonist Myoneural Interface for Functional Limb Restoration After Transtibial Amputation
NCT03913273
Financial Incentives for Care Gaps
NCT03715907
Motivating Survey Compliance: Game Play Study 1
NCT03738254
Computational Design, Fabrication, and Evaluation of Optimized Patient-Specific Transtibial Prosthetic Sockets
NCT03544853
Hydration Status Evaluation of Dehydrated Children With Experimental Devices
NCT02960789
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 1 |
What is open in the Massachusetts Institute of Technology pipeline
10 recruiting of 24 indexed (42% open); 7 completed (29%).
Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).
Top condition: Alzheimer Disease (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Massachusetts Institute of Technology: open-pipeline peers nationwide
Peers matched on 24 registered trials and 42% open enrollment, not the therapeutic-area sidebar.
Massachusetts Institute of Technology sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 24 trials (± recruiting share)
- Acrotech Biopharma · 24 trials · 8% recruiting
- Agenus · 24 trials · 0% recruiting
- Akebia Therapeutics · 24 trials · 4% recruiting
- Blueprint Medicines Corporation · 24 trials · 25% recruiting
Sponsors near 42% open enrollment (± trial volume)
- Arthrex · 42% recruiting · 12 trials
- Diwakar Davar · 42% recruiting · 12 trials
- Exactech · 42% recruiting · 12 trials
- Inari Medical · 42% recruiting · 12 trials
Related
What to do with this Massachusetts Institute of Technology page
24 registered trials is a research-attention snapshot, not an endorsement of Massachusetts Institute of Technology or any single study.
- 10 of Massachusetts Institute of Technology's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alzheimer Disease is the condition Massachusetts Institute of Technology studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimer Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Massachusetts Institute of Technology pipeline card: 24 registered trials from official public datasets.Report a data error.